[4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate

[ Molecular Formula ]:
C₃₁H₄₁BrFNO₃

[ Molecular Weight ]:
574.56500

[ Exact Mass ]:
573.22500

[ PSA ]:
46.61000

[ LogP ]:
8.16420

[ RIDADR ]:
NONH for all modes of transport

[Bromperidol decanoate in the residual phase of schizophrenia].

Minerva Psichiatr. 37(1) , 39-44, (1996)

We assessed the safety and therapeutic efficacy of bromperidol decanoate in a six-month open trial on 21 patients (13 males and 8 females), mean age 41.3 years, who were no longer in the acute phase a...

Depot bromperidol decanoate for schizophrenia.

Cochrane Database Syst. Rev. (3) , CD001719, (2004)

Antipsychotic drugs are the mainstay treatment for schizophrenia. Long-acting depot injections of drugs such as bromperidol decanoate are extensively used as a means of long-term maintenance treatment...

[Evaluation of effectiveness and tolerance of the long-term treatment with bromoperidol decanoate in psychotic disorders].

Minerva Psichiatr. 33(1) , 51-5, (1992)

An open study in 20 patients (7 M, 13 F, mean age 40 years) has been performed in order to evaluate the effectiveness and the safety of bromperidol decanoate in the long-term treatment of psychotic di...

More Articles